Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
A Berruti, M Tampellini, M Torta, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 1, 1991
Exogenous melatonin enhances the TRH-induced prolactin release in normally cycling women: a sex-specific effect
M Terzolo, A Piovesan, G Osella, et al.
Chronobiology International
|
January 1, 1990
Circadian profile of serum melatonin in Cushing's disease and acromegaly
A Piovesan, M Terzolo, G Borretta, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Melatonin and human cancer
L Dogliotti, A Berruti, T Buniva, et al.
Cancer Chemotherapy and Pharmacology
|
March 6, 1998
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study
L Dogliotti, S Danese, A Berruti, et al.
British Journal of Cancer
|
January 1, 1997
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease
M Tampellini, A Berruti, A Gerbino, et al.
Tumori
|
June 10, 1998
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases
D Fontana, O Bertetto, G Fasolis, et al.
Anticancer Research
|
July 1, 1997
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival
A Berruti, P Zola, T Buniva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial
L Dogliotti, A Berruti, T Buniva, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
A Berruti, M Tampellini, M Torta, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 1, 1991
Exogenous melatonin enhances the TRH-induced prolactin release in normally cycling women: a sex-specific effect
M Terzolo, A Piovesan, G Osella, et al.
Chronobiology International
|
January 1, 1990
Circadian profile of serum melatonin in Cushing's disease and acromegaly
A Piovesan, M Terzolo, G Borretta, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Melatonin and human cancer
L Dogliotti, A Berruti, T Buniva, et al.
Cancer Chemotherapy and Pharmacology
|
March 6, 1998
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study
L Dogliotti, S Danese, A Berruti, et al.
British Journal of Cancer
|
January 1, 1997
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease
M Tampellini, A Berruti, A Gerbino, et al.
Tumori
|
June 10, 1998
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases
D Fontana, O Bertetto, G Fasolis, et al.
Anticancer Research
|
July 1, 1997
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival
A Berruti, P Zola, T Buniva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial
L Dogliotti, A Berruti, T Buniva, et al.
Page
of 1